Curies, and Grays, and Sieverts, Oh My: A Guide for Discussing Radiation Dose and Risk of Molecular Breast Imaging.
作者信息
Hruska Carrie B, O'Connor Michael K
机构信息
Department of Radiology, Rochester, Minnesota.
Department of Radiology, Rochester, Minnesota.
出版信息
J Am Coll Radiol. 2015 Oct;12(10):1103-5. doi: 10.1016/j.jacr.2015.07.001.
Abstract
摘要
相似文献
1
Curies, and Grays, and Sieverts, Oh My: A Guide for Discussing Radiation Dose and Risk of Molecular Breast Imaging.居里、戈瑞和希沃特，天哪：分子乳腺成像辐射剂量与风险讨论指南
J Am Coll Radiol. 2015 Oct;12(10):1103-5. doi: 10.1016/j.jacr.2015.07.001.
2
Justification of the hybrid nuclear medicine examinations.
Radiat Prot Dosimetry. 2015 Jul;165(1-4):47-9. doi: 10.1093/rpd/ncv062. Epub 2015 Mar 23.
3
The Integration of LNT and Hormesis for Cancer Risk Assessment Optimizes Public Health Protection.将线性无阈模型（LNT）与兴奋效应整合用于癌症风险评估可优化公共卫生保护。
Health Phys. 2016 Mar;110(3):256-9. doi: 10.1097/HP.0000000000000382.
4
Radiation effects and risks: overview and a new risk perception index.
Radiat Prot Dosimetry. 2015 Jul;165(1-4):7-9. doi: 10.1093/rpd/ncv117. Epub 2015 Apr 1.
5
On the estimation of radiation-induced cancer risks from very low doses of radiation and how to communicate these risks.关于极低剂量辐射所致癌症风险的评估以及如何传达这些风险。
Radiat Prot Dosimetry. 2015 Jul;165(1-4):17-21. doi: 10.1093/rpd/ncv037. Epub 2015 Mar 22.
6
To Scan or not to Scan: Consideration of Medical Benefit in the Justification of CT Scanning.扫描与否：CT扫描合理性中医疗效益的考量
Health Phys. 2016 Mar;110(3):287-90. doi: 10.1097/HP.0000000000000391.
7
Russian practical guidance on radiological support for justification of X-ray and nuclear medicine examinations.俄罗斯关于X射线和核医学检查正当性的放射学支持实用指南。
Radiat Prot Dosimetry. 2015 Jul;165(1-4):39-42. doi: 10.1093/rpd/ncv127. Epub 2015 Apr 9.
8
Breast cancer incidence in U.S. radiologic technologists.美国放射技师的乳腺癌发病率。
Cancer. 2006 Jun 15;106(12):2707-15. doi: 10.1002/cncr.21876.
9
Low-dose radiation use in diagnostic imaging and cancer therapy settings.诊断成像和癌症治疗环境中的低剂量辐射使用。
Radiol Med. 2018 Aug;123(8):618-619. doi: 10.1007/s11547-018-0892-5. Epub 2018 Apr 18.
10
Calculating disability-adjusted life years (DALY) as a measure of excess cancer risk following radiation exposure.计算伤残调整生命年（DALY），作为辐射暴露后癌症超额风险的一种衡量指标。
J Radiol Prot. 2015 Dec;35(4):763-75. doi: 10.1088/0952-4746/35/4/763. Epub 2015 Oct 12.
引用本文的文献
1
Current Concepts in Molecular Breast Imaging.分子乳腺成像的当前概念
J Breast Imaging. 2025 Jan 25;7(1):104-118. doi: 10.1093/jbi/wbae076.
2
Case report: Possible role of low-dose PEM for avoiding unneeded procedures associated with false-positive or equivocal breast MRI results.病例报告：低剂量钆双胺增强磁共振成像在避免与乳腺磁共振成像假阳性或不确定结果相关的不必要检查中的潜在作用
Front Oncol. 2024 Jul 18;14:1405404. doi: 10.3389/fonc.2024.1405404. eCollection 2024.
3
Molecular Breast Imaging Biopsy with a Dual-Detector System.双探测器系统下的分子乳腺影像活检。
Radiol Imaging Cancer. 2024 Jun;6(4):e230186. doi: 10.1148/rycan.230186.
4
Evaluation of a High-Sensitivity Organ-Targeted PET Camera.高灵敏度器官靶向 PET 相机的评估。
Sensors (Basel). 2022 Jun 21;22(13):4678. doi: 10.3390/s22134678.
5
Updates in Molecular Breast Imaging.分子乳腺成像的最新进展。
Semin Roentgenol. 2022 Apr;57(2):134-138. doi: 10.1053/j.ro.2021.12.006. Epub 2021 Dec 31.
6
Let's Get Real about Molecular Breast Imaging and Radiation Risk.让我们正视分子乳腺成像与辐射风险。
Radiol Imaging Cancer. 2019 Sep 27;1(1):e190070. doi: 10.1148/rycan.2019190070. eCollection 2019 Sep.
7
Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis.分子乳腺成像、二维全视野数字化乳腺摄影与断层合成及合成乳腺断层摄影的辐射风险与获益比比较。
Radiol Imaging Cancer. 2019 Sep 27;1(1):e190005. doi: 10.1148/rycan.2019190005. eCollection 2019 Sep.
8
Molecular breast imaging detected invasive lobular carcinoma in dense breasts: A case report.分子乳腺成像在致密型乳腺中检测到浸润性小叶癌：一例报告。
Clin Case Rep. 2019 Jan 28;7(3):442-444. doi: 10.1002/ccr3.1945. eCollection 2019 Mar.
9
Use of Breast-Specific PET Scanners and Comparison with MR Imaging.乳腺专用PET扫描仪的应用及其与磁共振成像的比较。
Magn Reson Imaging Clin N Am. 2018 May;26(2):265-272. doi: 10.1016/j.mric.2017.12.006.
10
Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study.分子乳腺成像中背景实质摄取作为乳腺癌风险因素的病例对照研究。
Breast Cancer Res. 2016 Apr 26;18(1):42. doi: 10.1186/s13058-016-0704-6.
本文引用的文献
1
Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.乳腺钼靶致密型乳房单次补充性分子乳腺成像筛查的诊断检查及费用
AJR Am J Roentgenol. 2015 Jun;204(6):1345-53. doi: 10.2214/AJR.14.13306.
2
Radiation risks of medical imaging: separating fact from fantasy.医学影像辐射风险：明辨事实与幻想。
Radiology. 2012 Aug;264(2):312-21. doi: 10.1148/radiol.12112678.
3
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.在乳腺癌风险升高的女性中，通过每年进行乳腺筛查超声或单次乳腺筛查 MRI 检查来检测乳腺癌。
JAMA. 2012 Apr 4;307(13):1394-404. doi: 10.1001/jama.2012.388.
4
FDA, off-label use, and informed consent: debunking myths and misconceptions.美国食品药品监督管理局、药品未标示用途与知情同意：破除迷思与误解
Food Drug Law J. 1998;53(1):71-104.
Zotero 插件